Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa ; volume:22 ; number:1 ; day:5 ; month:3 ; year:2022 ; pages:1-15 ; date:12.2022
BMC health services research ; 22, Heft 1 (5.3.2022), 1-15, 12.2022
- Creator
-
Boyer, Sylvie
Baudoin, Maël
Nishimwe, Marie Libérée
Santos, Melina
Lemoine, Maud
Maradan, Gwenaëlle
Sylla, Babacar
Kouanfack, Charles
Carrieri, Patrizia
Mourad, Abbas
Rouveau, Nicolas
Moh, Raoul
Seydi, Moussa
Attia, Alain
Woode, Maame Esi
Lacombe, Karine
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-021-07289-0
- URN
-
urn:nbn:de:101:1-2022060200034939999251
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boyer, Sylvie
- Baudoin, Maël
- Nishimwe, Marie Libérée
- Santos, Melina
- Lemoine, Maud
- Maradan, Gwenaëlle
- Sylla, Babacar
- Kouanfack, Charles
- Carrieri, Patrizia
- Mourad, Abbas
- Rouveau, Nicolas
- Moh, Raoul
- Seydi, Moussa
- Attia, Alain
- Woode, Maame Esi
- Lacombe, Karine
- SpringerLink (Online service)
Other Objects (12)
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
Action Recommended
Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients
Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials
Sofosbuvir: Nutzenbewertung gemäß § 35a SGB V
Addendum zum Auftrag A14-05 (Sofosbuvir)
High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting
Python Not Recommended
Personas - recommended readings
EFSUMB Recommended Reads
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
Action Recommended
Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients
Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials
Sofosbuvir: Nutzenbewertung gemäß § 35a SGB V
Addendum zum Auftrag A14-05 (Sofosbuvir)
High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting
Python Not Recommended
Personas - recommended readings
EFSUMB Recommended Reads
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
Action Recommended
Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients
Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials
Sofosbuvir: Nutzenbewertung gemäß § 35a SGB V
Addendum zum Auftrag A14-05 (Sofosbuvir)
High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting
Python Not Recommended
Personas - recommended readings
EFSUMB Recommended Reads